Transcranial direct current stimulation for Autism Spectrum Disorder
Phase-Based Progress Estimates
Effectiveness
Safety
American University, Washington, United States
Autism Spectrum Disorder+2 More
Transcranial direct current stimulation - DeviceEligibility
18 - 65
All Sexes
What conditions do you have?
Select
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select
Study Summary
The goal of this study is to determine the impact of neuromodulation to the cerebellum on social and executive functions in neurotypical young adults and young adults with autism.
Eligible Conditions
- Autism Spectrum Disorder
- Autism, Early Infantile
Treatment Effectiveness
Effectiveness Progress
Other trials for Autism Spectrum Disorder
Study Objectives
4 Primary · 0 Secondary · Reporting Duration: Within 30min post-tDCS
Within 30min post-tDCS
Cyberball social ball-playing task
Flexible Item Selection Test
Reading the Mind in the Eyes Test Adult Version
Within 45min post-tDCS
Functional MRI data
Trial Safety
Safety Progress
Other trials for Autism Spectrum Disorder
Trial Design
2 Treatment Groups
Right cerebellum
1 of 2
Posterior vermis
1 of 2
Experimental Treatment
80 Total Participants · 2 Treatment Groups
Primary Treatment: Transcranial direct current stimulation · No Placebo Group · N/A
Right cerebellum
Device
Experimental Group · 1 Intervention: Transcranial direct current stimulation · Intervention Types: DevicePosterior vermis
Device
Experimental Group · 1 Intervention: Transcranial direct current stimulation · Intervention Types: DeviceTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial direct current stimulation
2019
Completed Phase 3
~690
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: within 30min post-tdcs
Closest Location: American University · Washington, United States
2007First Recorded Clinical Trial
1 TrialsResearching Autism Spectrum Disorder
9 CompletedClinical Trials
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,390 Previous Clinical Trials
24,521,477 Total Patients Enrolled
19 Trials studying Autism Spectrum Disorder
2,341 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,490 Previous Clinical Trials
1,765,991 Total Patients Enrolled
70 Trials studying Autism Spectrum Disorder
37,618 Patients Enrolled for Autism Spectrum Disorder
American UniversityLead Sponsor
18 Previous Clinical Trials
4,525 Total Patients Enrolled
Catherine Stoodley, D.Phil.Principal InvestigatorAmerican University
Eligibility Criteria
Age 18 - 65 · All Participants · 10 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You are aged 18-35.
You are a native English speaker.
You are right-handed.
You are not pregnant.\n
Pass MRI and neuromodulation safety screening.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments